Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 10, 2008, Pages 907-913

  Bocchino, M ^a   Matarese, A ^a   Bellofiore, B ^a   Giacomelli, P ^a   Santoro, G ^b   Balato, N ^a   Castiglione, F ^a   Scarpa, R ^a   Perna, F ^a   Signoriello, G ^c   Galati, D ^a   Ponticiello, A ^a   Sanduzzi, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROCTOCOLITIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCREENING; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; ITALY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 53549089852     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0519-1     Document Type: Article

References (42)

1. MP Moiton C Richez C Dumoulin N Mehsen J Dehais T Schaeverbeke 2006 Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections Clin Microbiol Infect 12 1151 1153
2. KL Winthrop 2006 Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor Nat Clin Pract Rheumatol 2 602 610
3. H Hamdi X Mariette V Godot K Weldingh AM Hamid MV Prejean G Baron M Lemann X Puechal M Breban F Berenbaum JC Delchier RM Flipo B Dautzenberg D Salmon M Humbert D Emilie RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group 2006 Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists Arthritis Res Ther 8 R114
4. OY Saliu C Sofer DS Stein SK Schwander RS Wallis 2006 Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity J Infect Dis 194 486 492
5. Joint Tuberculosis Committee of the British Thoracic Society 2005 BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment Thorax 60 800 805
6. G Valesini C Montecucco M Cutolo 2006 Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy Clin Exp Rheumatol 24 413 423
7. G Provenzano MC Ferrante G Simon 2005 TB screening and anti-TNF alpha treatment Thorax 60 613
8. D Menzies 1999 Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion Am J Respir Crit Care Med 159 15 21
9. RE Huebner MF Schein JB Bass Jr 1993 The tuberculin skin test Clin Infect Dis 17 968 975
10. PF Barnes 2001 Diagnosing latent tuberculosis infection: the 100-year upgrade Am J Respir Crit Care Med 163 807 808
11. T Mori M Sakatani F Yamagishi T Takashima Y Kawabe K Nagao E Shigeto N Harada S Mitarai M Okada K Suzuki Y Inoue K Tsuyuguchi Y Sasaki GH Mazurek I Tsuyuguchi 2004 Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens Am J Respir Crit Care Med 170 59 64
12. A Lalvani AA Pathan H McShane RJ Wilkinson M Latif CP Conlon G Pasvol AV Hill 2001 Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Am J Respir Crit Care Med 163 824 828
13. JS Rothel P Andersen 2005 Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 3 981 993
14. M Pai LW Riley JM Colford Jr 2004 Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 761 476
15. T Meier HP Eulenbruch P Wrighton-Smith G Enders T Regnath 2005 Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice Eur J Clin Microbiol Infect Dis 24 529 536
16. P Ravn ME Munk AB Andersen B Lundgren JD Lundgren LN Nielsen A Kok-Jensen P Andersen K Weldingh 2005 Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis Clin Diagn Lab Immunol 12 491 496
17. JY Lee HJ Choi IN Park SB Hong YM Oh CM Lim SD Lee Y Koh WS Kim DS Kim WD Kim TS Shim 2006 Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection Eur Respir J 28 24 30
18. A Lalvani AA Pathan H Durkan KA Wilkinson JJ Deeks WH Reece M Latif G Pasvol AV Hill 2001 Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Lancet 357 2017 2021
19. K Ewer J Deeks L Alvarez G Bryant S Waller P Anderson P Monk A Lalvani 2003 Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak Lancet 361 1168 1173
20. AL Chapman M Munkanta KA Wilkinson AA Pathan K Ewer H Ayles WH Reece A Mwinga P Godfrey-Faussett A Lalvani 2002 Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells AIDS 16 2285 2293
21. S Liebeschuetz S Bamber K Ewer J Deeks AA Pathan A Lalvani 2004 Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study Lancet 364 2196 2203
22. M Hoffmann M Reichmuth K Fantelli OD Schoch W Fierz H Furrer P Vernazza 2007 Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients AIDS 21 390 392
23. SA Clark SL Martin A Pozniak A Steel B Ward J Dunning DC Henderson M Nelson B Gazzard P Kelleher 2007 Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease Clin Exp Immunol 150 238 244
24. American Thoracic Society 2000 Diagnostic standards and classification of tuberculosis in adults and children Am J Respir Crit Care Med 161 1376 1395
25. L Carmona JJ Gómez-Reino V Rodríguez-Valverde D Montero E Pascual-Gómez EM Mola L Carreño M Figueroa BIOBADASER Group 2005 Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 52 1766 1772
26. F Wolfe K Michaud J Anderson K Urbansky 2004 Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy Arthritis Rheum 50 372 379
27. J Askling CM Fored L Brandt E Baecklund L Bertilsson L Cöster P Geborek LT Jacobsson S Lindblad J Lysholm S Rantapää-Dahlqvist T Saxne V Romanus L Klareskog N Feltelius 2005 Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden Arthritis Rheum 52 1986 1992
28. YA Kang HW Lee HI Yoon B Cho SK Han YS Shim JJ Yim 2005 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country JAMA 293 2756 2761
29. G Ferrara M Losi M Meacci B Meccugni R Piro P Roversi BM Bergamini R D'Amico P Marchegiano P Rumpianesi LM Fabbri L Richeldi 2005 Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection Am J Respir Crit Care Med 172 631 635
30. G Ferrara M Losi R D'Amico P Roversi R Piro M Meacci B Meccugni IM Dori A Andreani BM Bergamini C Mussini F Rumpianesi LM Fabbri L Richeldi 2006 Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study Lancet 367 1328 1334
31. TG Connell N Curtis SC Ranganathan JP Buttery 2006 Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children Thorax 61 616 620
32. F Piana LR Codecasa P Cavallerio M Ferrarese GB Migliori L Barbarano E Morra DM Cirillo 2006 Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients Eur Respir J 28 31 34
33. SM Arend SF Thijsen EM Leyten JJ Bouwman WP Franken BF Koster FG Cobelens AJ van Houte AW Bossink 2007 Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts Am J Respir Crit Care Med 175 618 627
34. D Menzies M Pai G Comstock 2007 Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research Ann Intern Med 146 340 354
35. AF Luetkemeyer ED Charlebois LL Flores DR Bangsberg SG Deeks JN Martin DV Havlir 2007 Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals Am J Respir Crit Care Med 175 737 742
36. K Dheda A Lalvani RF Miller G Scott H Booth MA Johnson A Zumla GA Rook 2005 Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count AIDS 19 2038 2041
37. GH Mazurek J Jereb P Lobue MF Iademarco B Metchock A Vernon Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC) 2005 Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States MMWR Recomm Rep 54 49 55
38. National Collaborating Centre for Chronic Conditions (2006) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, London, UK
39. Documento sull'utilizzo dei nuovi test immunologici per la diagnosi di infezione tubercolare latente. Elaborato dei Gruppi di Studio Infezioni e Tubercolosi dell'Associazione Italiana Pneumologi Ospedalieri (AIPO) e della Società Italiana di Medicina Respiratoria (SIMeR). 15 giugno 2006, http://www.simernet.it
40. BE Joven R Almodóvar M Galindo I Mateo JL Pablos 2006 Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response? Ann Rheum Dis 65 699
41. L Richeldi K Ewer M Losi P Roversi LM Fabbri A Lalvani 2006 Repeated tuberculin testing does not induce false positive ELISPOT results Thorax 61 180
42. L Richeldi 2007 Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy? Am J Respir Crit Care Med 175 200